September 23-24: Conference
Clinical trial information transparency is taking on new dimensions. Clinical trial sponsors and academia are facing a host of new registration requirements in the US, EU, and elsewhere. With evolving requirements comes new challenges, creating additional opportunities for knowledge-sharing and necessitating more interaction with peers. This conference will provide critical and timely information relating to global clinical trial disclosure and data transparency from those on the front lines.
While we develop our 2024 agenda, please take a moment to review the 2021 final agenda.
Thanks for organizing such a nice conference on CTD and Trial Transparency. It was my first experience attending the DIA conference and I learnt new initiatives taken across industry.” – Ravi Jogai, Associate Director - Syneos Health (Seasoned Clinical Research Professional)
Want to learn more about Global Clinical Trial Disclosure and Data Transparency Conference? You've come to the right site!
Kelly Coulbourne, MS Director, Clinical Trial Disclosure and Data Transparency
Pfizer Inc, United States
Robert Paarlberg, MS Principal
Representative Invited DIA, United States